☆ 4.4 Article

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care

TRIALS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad A. Bousman et al.

Summary: Selective serotonin reuptake inhibitors (SSRIs) are the primary pharmacologic treatments for major depressive and anxiety disorders. Genetic variation in CYP2D6, CYP2C19, and CYP2B6 can affect the metabolism of these antidepressants, potentially impacting dosing, efficacy, and tolerability. The SLC6A4 and HTR2A genes have been studied for their relationship with efficacy and side effect profiles of these drugs. This guideline updates and expands on the role of genetic factors in antidepressant response and provides recommendations for using genotype results to guide prescribing decisions.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Economic evaluation of the Target-D platform to match depression management to severity prognosis in primary care: A within-trial cost-utility analysis

Yong Yi Lee et al.

Summary: This study evaluated the cost-effectiveness of Target-D compared to usual care and found that Target-D is likely to be cost-effective in both health sector and partial societal perspectives. It provides a valuable option for healthcare decision makers.

PLOS ONE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials

Lisa C. Brown et al.

Summary: This study systematically reviewed and meta-analyzed the association between PGx-guided antidepressant therapy and depressive symptom remission in MDD patients. The results suggest that PGx-guided antidepressant therapy is modestly but significantly associated with an increase in depressive symptom remission in adults with MDD.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Primary Health Care

Economic evaluation of a Decision Support Tool to guide intensity of mental health care in general practice: the Link-me pragmatic randomised controlled trial

Mary Lou Chatterton et al.

Summary: This paper presents the cost-effectiveness evaluation of Link-me, a digitally supported approach to triaging care for depression and anxiety in primary care. The findings suggest that Link-me shows a trend towards cost-effectiveness by providing improvement in mental health symptoms at an additional cost.

BMC PRIMARY CARE (2022)

添加到收藏夹

Article Primary Health Care

Matching depression management to severity prognosis in primary care: results of the Target-D randomised controlled trial

Susan Fletcher et al.

Summary: The study aimed to investigate whether a person-centred e-health platform matching depression care to symptom severity prognosis can improve depressive symptoms. The results showed that the intervention group had improved depressive symptoms at 3 months, with no serious adverse events reported, indicating that this management approach is feasible and could potentially be implemented on a larger scale.

BRITISH JOURNAL OF GENERAL PRACTICE (2021)

添加到收藏夹

Article Medicine, General & Internal

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

Damian F. Santomauro et al.

Summary: This study aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. The findings showed that the pandemic led to increased prevalence of major depressive disorder and anxiety disorders, with females and younger age groups being more affected. The pandemic has created an increased urgency to strengthen mental health systems in most countries and mitigation strategies are needed to address the burden of these mental disorders.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Antidepressant prescribing in general practice: A call to action

Katharine A Wallis et al.

Australian Journal of General Practice (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations

Chad A. Bousman et al.

Summary: Pharmacogenomic (PGx) testing is increasingly used in clinics and the commercial industry, but not all tests have consistent standards for translating results into prescribing recommendations. Sequence2Script is a web-based tool designed to assist users in efficiently translating PGx testing results into evidence-based prescribing recommendations. This tool supports 97 gene-drug pairs and allows users to adjust recommendations, generating a clinical report summarizing patient genotype and prescribing recommendations. The hope is that Sequence2Script will help standardize the use of PGx testing results and reduce barriers to implementation in practice.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence

Amy Hai Yan Chan et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients

Chaten D. Jessel et al.

PHARMACOGENETICS AND GENOMICS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent

Colleen E. Lawrence et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Meeting Abstract Clinical Neurology

Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls

K. Koehler-Forsberg et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Spencer L. G. James et al.

LANCET (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update

J. K. Hicks et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Clinical Neurology

Identifying depression with the PHQ-2: A diagnostic meta-analysis

Laura Manea et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

添加到收藏夹

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Review Health Policy & Services

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013

David A. Mrazek et al.

PSYCHIATRIC SERVICES (2014)

添加到收藏夹

Article Medicine, General & Internal

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

An-Wen Chan et al.

ANNALS OF INTERNAL MEDICINE (2013)

添加到收藏夹

Article Neurosciences

Contribution of Common Genetic Variants to Antidepressant Response

Katherine E. Tansey et al.

BIOLOGICAL PSYCHIATRY (2013)

添加到收藏夹

Article Medicine, General & Internal

Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

Alize J. Ferrari et al.

PLOS MEDICINE (2013)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacogenetics: From Bench to Byte-An Update of Guidelines

J. J. Swen et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)

添加到收藏夹

Article Primary Health Care

Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population

Bruce Arroll et al.

ANNALS OF FAMILY MEDICINE (2010)

添加到收藏夹

Article Psychiatry

Relationship between antidepressant medication possession and treatment response

John C. Fortney et al.

GENERAL HOSPITAL PSYCHIATRY (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

Michael E. Thase et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

添加到收藏夹

Article Health Care Sciences & Services

The PHQ-9 - Validity of a brief depression severity measure

K Kroenke et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2001)

添加到收藏夹

Article Psychiatry

Who uses mental health services in Australia? An analysis of data from the National Survey of Mental Health and Wellbeing

RA Parslow et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.